WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017056109) NOVEL FORMS OF LUMACAFTOR AND PROCESSES FOR THE PREPARATION THEREOF
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/056109 International Application No.: PCT/IN2016/050326
Publication Date: 06.04.2017 International Filing Date: 28.09.2016
IPC:
C07D 405/12 (2006.01)
Applicants: MYLAN LABORATORIES LIMITED[IN/IN]; Plot No 564/A/22, Road No 92, Jubilee Hills, Hyderabad 500033, IN
Inventors: JETTI, Ramakoteswara Rao; IN
MANDE, Hemant Malhari; IN
INDUKURI, Anjaneyaraju; IN
AGGIRAMIREDDY, Bommareddy; IN
BHAGAVATULA, Neelima; IN
SINGH, Amit; IN
GHOSH, Soumyajit; IN
SRINIVASARAO, Attanti Veera Venkata; IN
TUMMALAPALLI, Umasankara Sastry; IN
GOSULA, Veera Venkata Satya Surya Appala Narasimha Tataji; IN
Agent: HASAN, Afzal; IN
HASAN, Vatsala Singh; IN
Priority Data:
20164100708501.03.2016IN
5209/CHE/201529.09.2015IN
Title (EN) NOVEL FORMS OF LUMACAFTOR AND PROCESSES FOR THE PREPARATION THEREOF
(FR) NOUVELLES FORMES DE LUMACAFTOR ET LEURS PROCÉDÉS DE PRÉPARATION
Abstract: front page image
(EN) The present disclosure provides amorphous lumacaftor, amorphous solid dispersions of lumacaftor, crystalline lumacaftor acetic acid solvate, crystalline lumacaftor ethyl acetate solvate, and processes for the preparation thereof. The lumacaftor forms disclosed herein may be useful for the preparation of oral dosage forms for treating cystic fibrosis transmembrane conductance regulator (CFTR) mediated diseases.
(FR) La présente invention concerne du lumacaftor amorphe, des dispersions solides amorphes de lumacaftor, un solvate d'acide acétique de lumacaftor cristallin, un solvate d'acétate d'éthyle de lumacaftor cristallin, et leurs procédés de préparation. Les formes de lumacaftor décrites dans la présente description peuvent être utiles pour la préparation de formes galéniques destinées à être administrées par voie orale pour le traitement de maladies à médiation par le régulateur de la conductance transmembranaire de la fibrose kystique (CFTR).
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)